Devashan Naidoo

Dr. Devashan Naidoo

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2020 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
PKPallab Kar
Pallab Kar
VKVijay Kumar
Vijay Kumar
BVBalachandar Vellingiri
Balachandar Vellingiri
ASArnab Sen
Arnab Sen
NJNishika Jaishee
Nishika Jaishee
MSMohana Devi Subramaniam
Mohana Devi Subramaniam
The coronavirus disease 2019 (COVID-19) pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), presents an unprecedented challenge to global public health with researchers striving to find a possible therapeutic candidate that could limit the spread of the virus. In this context, the present study employed an in silico molecular interaction-based approach to estimate the inhibitory potential of the phytochemicals from ethnomedicinally relevant Indian plants including Justicia adhatoda, Ocimum sanctum and Swertia chirata, with reported antiviral activities against crucial SARS-CoV-2 proteins. SARS-CoV-2 proteins associated with host attachment and viral replication namely, spike protein, main protease enzyme Mpro and RNA-dependent RNA polymerase (RdRp) are promising druggable targets for COVID-19 therapeutic research. Extensive molecular docking of the phytocompounds at the binding pockets of the viral proteins revealed their promising inhibitory potential. Subsequent assessment of physicochemical features and potential toxicity of the compounds followed by robust molecular dynamics simulations and analysis of MM-PBSA energy scoring function revealed anisotine against SARS-CoV-2 spike and Mpro proteins and amarogentin against SARS-CoV-2 RdRp as potential inhibitors. It was interesting to note that these compounds displayed significantly higher binding energy scores against the respective SARS-CoV-2 proteins compared to the relevant drugs that are currently being targeted against them. Present research findings confer scopes to explore further the potential of these compounds in vitro and in vivo towards deployment as efficient SARS-CoV-2 inhibitors and development of novel effective therapeutics. Communicated by Ramaswamy H. Sarma

21 July 2020 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
DNDevashan Naidoo
Devashan Naidoo
ARAyan Roy
Ayan Roy
PKPallab Kar
Pallab Kar
TMTaurai Mutanda
Taurai Mutanda
AAAkash Anandraj
Akash Anandraj
A novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) has emerged as the causative agent behind the coronavirus disease 2019 (COVID-19) pandemic. Treatment efforts have been severely impeded due to the lack of specific effective antiviral drugs for the treatment of COVID-associated pathologies. In the present research endeavour the inhibitory prospects of cyanobacterial metabolites were assessed at the active binding pockets of the two vital SARS-CoV-2 proteases namely, main protease (Mpro) and the papain-like protease (PLpro) that proteolytically process viral polyproteins and facilitate viral replication, employing an in silico molecular interaction-based approach. It was evident from our analysis based on the binding energy scores that the metabolites cylindrospermopsin, deoxycylindrospermopsin, carrageenan, cryptophycin 52, eucapsitrione, tjipanazole, tolyporphin and apratoxin A exhibited promising inhibitory potential against the SARS-CoV-2 Mpro. The compounds cryptophycin 1, cryptophycin 52 and deoxycylindrospermopsin were observed to display encouraging binding energy scores with the PLpro of SARS-CoV-2. Subsequent estimation of physicochemical properties and potential toxicity of the metabolites followed by robust molecular dynamics simulations and analysis of MM-PBSA energy scoring function established deoxycylindrospermopsin as the most promising inhibitory candidate against both SARS-CoV-2 proteases. Present research findings bestow ample scopes to further exploit the potential of deoxycylindrospermopsin as a successful inhibitor of SARS-CoV-2 in vitro and in vivo and pave the foundation for the development of novel effective therapeutics against COVID-19. Communicated by Ramaswamy H. Sarma

26 July 2022 in Cosmetics
Verified
Journal Article
Open access
PDF file
FGFikisiwe Gebashe
Fikisiwe Gebashe
DNDevashan Naidoo
Devashan Naidoo
Stephen AmooStephen Amoo
Stephen Amoo
NMNqobile A Masondo
Nqobile A Masondo
Africa is counted amongst the cosmetic market contributors; however, South Africa’s remarkable plant diversity is still largely untapped in terms of its potential for medicinal and cosmetic purposes. Thus, we aim to provide a critical assessment of the advancements made in South African cosmeceuticals with emphasis towards online local companies/brands that are manufactured by small, medium and micro enterprises (SMMEs). For the current study, we limited our search of herbal cosmeceutical products to SMMEs with online websites, or products traded in other online cosmetic directories such as ‘Faithful to Nature’ and ‘African Botanicals’ using a simple Google search. We recorded more than 50 South African SMME companies/brands involved in the trade of cosmeceuticals. Skin and hair care were the major product categories widely traded in these online platforms. Furthermore, few patents were recorded from South African researchers and institutions thereof, which is quite alarming considering the extensive research that has been undertaken to study these commercially valuable plants. Based on the increasing number of new products and the wide pool of economically important plants coupled to their associated rich indigenous knowledge systems, the cosmeceutical sector can contribute to the economy, job creation, entrepreneurship skills, socio-economic development and intellectual property generation.

27 March 2022 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PKPallab Kar
Pallab Kar
MSMoshfekus Saleh‐E‐In
Moshfekus Saleh‐E‐In
NJNishika Jaishee
Nishika Jaishee
AAAkash Anandraj
Akash Anandraj
EKEmil Kormuth
Emil Kormuth
YCYong E. Choi
Yong E. Choi

12 August 2015 in Plant Biology
Verified
Journal Article
Closed access
PDF file
HPHeino Benoni Papenfus
Heino Benoni Papenfus
DNDevashan Naidoo
Devashan Naidoo
MPMartin Pošta
Martin Pošta
JFJeffrey F. Finnie
Jeffrey F. Finnie
JSJohannes Van Staden
Johannes Van Staden

11 December 2017 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
DNDevashan Naidoo
Devashan Naidoo
LSLenka Poštová Slavětínská
Lenka Poštová Slavětínská
Adeyemi Oladapo AremuAdeyemi Oladapo Aremu
Adeyemi Oladapo Aremu
JGJiri Gruz
Jiri Gruz
OBOndrej Biba
Ondrej Biba
JFJeffrey F. Finnie
Jeffrey F. Finnie